These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues. Zhang W; Wu J; Li Y; Carke RC; Wong T Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098 [TBL] [Abstract][Full Text] [Related]
44. How far shall we go in the predonation selection of blood donors to safeguard patients for blood-transfusion-related infections? Vox Sang; 1993; 65(1):1-9. PubMed ID: 8362510 [No Abstract] [Full Text] [Related]
49. Blood test for variant Creutzfeldt-Jakob disease. Bennett P JAMA Neurol; 2014 Aug; 71(8):1054. PubMed ID: 25111210 [No Abstract] [Full Text] [Related]
50. Japan plans blood-donor restrictions to combat vCJD. Fuyuno I Nature; 2005 Mar; 434(7031):260. PubMed ID: 15772611 [No Abstract] [Full Text] [Related]
51. Testing times ahead -- if you were incubating "human BSE", would you want to know? Day M New Sci; 1999 Jan; 161(2170):5. PubMed ID: 11657933 [No Abstract] [Full Text] [Related]
52. Infectivity in the blood of mice with a BSE-derived agent. Taylor DM; Fernie K; Reichl HE; Somerville RA J Hosp Infect; 2000 Sep; 46(1):78-9. PubMed ID: 11023729 [No Abstract] [Full Text] [Related]
53. Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays. Cooper JK; Ladhani K; Minor PD Vox Sang; 2007 May; 92(4):302-10. PubMed ID: 17456154 [TBL] [Abstract][Full Text] [Related]
54. Impact of donor deferrals for malaria on blood availability in the United States. Leiby DA; Nguyen ML; Notari EP Transfusion; 2008 Oct; 48(10):2222-8. PubMed ID: 18673351 [TBL] [Abstract][Full Text] [Related]
55. Scientists race to develop a blood test for vCJD. Nat Med; 2001 Mar; 7(3):261. PubMed ID: 11231599 [No Abstract] [Full Text] [Related]
56. Blood test for variant Creutzfeldt-Jakob disease--reply. Jackson GS; Burk-Rafel J; Mead S; Collinge J JAMA Neurol; 2014 Aug; 71(8):1054-5. PubMed ID: 25111211 [No Abstract] [Full Text] [Related]
57. Blood to be screened for CJD. Morgan J BMJ; 1996 Aug; 313(7055):441. PubMed ID: 8776304 [No Abstract] [Full Text] [Related]
58. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment. Svae TE; Neisser-Svae A; Bailey A; Reichl H; Biesert L; Schmidt T; Heger A; Römisch J Transfus Apher Sci; 2008 Aug; 39(1):59-67. PubMed ID: 18619902 [TBL] [Abstract][Full Text] [Related]
60. Mad no more. Product designed to filter prions. Page L Mater Manag Health Care; 2005 Jan; 14(1):31. PubMed ID: 15727421 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]